학술논문
Validation of SKY92 high and low risk prognostication in a retrospective, multinational cohort of 155 non-trial multiple myeloma patients
Document Type
Abstract
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e60-e61
Subject
Language
ISSN
2152-2650